Centaur Diagnostics, Inc. v. Mittel

CourtDistrict Court, D. Massachusetts
DecidedNovember 25, 2019
Docket1:19-cv-11644
StatusUnknown

This text of Centaur Diagnostics, Inc. v. Mittel (Centaur Diagnostics, Inc. v. Mittel) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Centaur Diagnostics, Inc. v. Mittel, (D. Mass. 2019).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS

CIVIL ACTION NO. 19-11644-RGS

CENTAUR DIAGNOSTICS, INC.

v.

LOUIS MITTEL

ERIK DUHAIME

MEMORANDUM AND ORDER ON COUNTERCLAIM DEFENDANT AND THIRD-PARTY DEFENDANT’S MOTIONS TO DISMISS

November 25, 2019

STEARNS, D.J. As described in defendant Louis Mittel’s counterclaims (against Centaur Diagnostics, Inc.) and his third-party Complaint (against Erik Duhaime, Centaur’s CEO) (collectively counterclaims or CC), Mittel and Duhaime met in early 2013 while Mittel was a graduate student in statistics at Columbia University. Duhaime was then a student at MIT’s Sloan School of Management. Mittel shared with Duhaime his idea for an app, “similar to a dating app, to connect medical personnel with images, using statistics to generate better diagnoses for medical conditions, specifically for moles and skin conditions and the statistical methods to accomplish this.” CC ¶ 20. The two men discussed forming a company together based on Mittel’s idea, and in 2013 and 2014, engaged in numerous discussions about aspects of the

proposed venture. They also, however, “confirmed that they were committed to obtaining their Ph.D.[’]s prior to launching a business.” CC ¶ 26. In March of 2017, without informing Mittel, Duhaime incorporated Centaur in Delaware. In the summer of 2017, Mittel introduced Duhaime to several

business advisors and potential investors. After graduating in August of 2018, Mittel formally sought to join Centaur. During the course of negotiations, citing to limitations imposed by

Centaur’s participation in start-up incubation programs and conditions of investment funding, the amount of equity Duhaime offered to Mittel decreased from 10-15% (October of 2018, CC ¶ 46), to 5% (February of 2019, CC ¶ 56), and ultimately to 1.5% (April of 2019, CC ¶ 66). Mittel and Duhaime

came to a final agreement on the terms of Mittel’s employment in May of 2019. Mittel rejected a requirement that he relocate from New York to Boston (where Centaur is based). As a compromise, Mittel and Duhaime agreed that Mittel’s position as Chief Data Officer would be “based in

Boston.” CC ¶ 76. In terms of compensation, Mittel was to be paid an annual salary of $125,000 with a signing bonus of $30,000, and the right to purchase, at $.07 a share, 78,402 shares (1.5%) of Centaur stock. The stock was to be released to Mittel according to a vesting schedule set out in a Stock Purchase Agreement (SPA), beginning with the completion of one year of

employment at Centaur or upon an earlier discharge without cause. In the event of a discharge with cause, Centaur had the right to repurchase Mittel’s shares. Mittel also signed a one-year post-employment non-competition agreement in exchange for four payments totaling half his annual salary.

Mittel started at Centaur on May 20, 2019 and tendered a check for $5,488.15 for the stock purchase. According to Mittel, he quickly realized that his was not the leadership role that Duhaime had promised during their

negotiations, and that further, Duhaime expected him to work full-time out of Centaur’s Boston office. Mittel offered to relocate to Boston in exchange for a 5% stake in Centaur, but Duhaime refused. In late June, Duhaime caused Centaur to adopt a policy requiring employees to be physically

present in the Boston office from 9:30am to 6pm on weekdays unless excused by a manager. Because other employees were permitted to work remotely but he was not, Mittel believed that the policy was targeted at him to manufacture a reason to dismiss him for cause.

Centaur preemptively filed its Complaint against Mittel on July 31, 2019 (seeking declaratory judgment of the terms of Mittel’s employment, his intellectual property rights, and his rights under the stock purchase agreement, while asserting that Mittel had breached his employment agreement). On August 2, 2019, Centaur terminated Mittel for cause, citing,

inter alia, his absences from Centaur’s Boston office. Mittel responded with the Amended Counterclaims on September 26, 2019, asserting claims against Centaur and Duhaime for deceit and negligent misrepresentation (Counts I & II), against Centaur for rescission, breach of contract, and

violation of the covenant of good faith and fair dealing (Counts III, V, and VI); and against Duhaime for breach of fiduciary duty, unjust enrichment, and violation of the Massachusetts Fair Business Practices Act, Gen. Laws

ch. 93A (Counts IV, VII, and VIII). Centaur and Duhaime move to dismiss the Counterclaims for failure to state claims for which relief may be granted under Fed. R. Civ. P. 12(b)(6). DISCUSSION

To survive a Rule 12(b)(6) motion to dismiss, the factual allegations of a complaint must “possess enough heft” to set forth “a plausible entitlement to relief.” Bell Atl. Corp. v. Twombly, 550 U.S. 544, 557, 559 (2007); Thomas v. Rhode Island, 542 F.3d 944, 948 (1st Cir. 2008). As the Supreme Court

has emphasized, this standard “demands more than an unadorned, the- defendant-unlawfully-harmed-me accusation. A pleading that offers labels and conclusions or a formulaic recitation of the elements of a cause of action will not do. Nor does a complaint suffice if it tenders naked assertion[s] devoid of further factual enhancement.” Ashcroft v. Iqbal, 556 U.S. 662, 678

(2009) (internal citations and quotation marks omitted). Deceit and Negligent Misrepresentation Mittel alleges that to induce him to join Centaur at a lower equity interest than he was initially promised, Duhaime knowingly, recklessly, or

negligently made a series of false statements.1 These include: a. By email of April 1, 2019, Duhaime told Mittel that he would be an important part of the senior leadership/executive team; b. By phone in late April of 2019, Duhaime told Mittel that he would be invited to California as part of the leadership team over the summer (presumably to meet with investors); c. In late March of 2019, Duhaime told Mittel that he would be responsible for selecting interns from a pool of 100 candidates and by email of April 4, 2019, he told Mittel that he would be responsible for supervising the interns; d. By email of April 4, 2019, Duhaime told Mittel that he would participate in decisions about office location; e. By email of April 1, 2019, Duhaime told Mittel that he could not grant him the equity interest they had discussed (10- 15%) based upon the feedback from [startup incubator] YC and Steve Loughlin [of Accel, a venture capital investor in Centaur], but Duhaime never disclosed Mittel’s role in the founding of the business to YC or Accel; f. By email of April 1, 2019 and in subsequent conversations, Duhaime told Mittel that [Centaur] would never

1 In his employment agreement, Mittel agreed that claims arising out of his relationship with Centaur would be governed by Massachusetts law. See Dkt # 6-1 at 3. agree to grant an equity interest of more than 3% to any employee moving forward (with the sole exception of a “genius 50 year old executive type who is making $1m/year and we need desperately for some reason”) and laid out the parameters for equity grants going forward; g. By email of April 1, 2019 and in phone conversations in late 2018 and early 2019, Duhaime told Mittel that it might well make sense for Mittel to build out the data team in New York instead of in Boston; h.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Thomas v. Rhode Island
542 F.3d 944 (First Circuit, 2008)
Bose Corporation v. Ejaz
732 F.3d 17 (First Circuit, 2013)
Singarella v. City of Boston
173 N.E.2d 290 (Massachusetts Supreme Judicial Court, 1961)
McCartin v. Westlake
630 N.E.2d 283 (Massachusetts Appeals Court, 1994)
Gurry v. Cumberland Farms, Inc.
550 N.E.2d 127 (Massachusetts Supreme Judicial Court, 1990)
Worcester Heritage Society, Inc. v. Trussell
577 N.E.2d 1009 (Massachusetts Appeals Court, 1991)
Anthony's Pier Four, Inc. v. HBC ASSOCIATES
583 N.E.2d 806 (Massachusetts Supreme Judicial Court, 1991)
Starr v. Fordham
648 N.E.2d 1261 (Massachusetts Supreme Judicial Court, 1995)
Demoulas v. Demoulas
428 Mass. 555 (Massachusetts Supreme Judicial Court, 1998)
International Totalizing Systems, Inc. v. PepsiCo, Inc.
29 Mass. App. Ct. 424 (Massachusetts Appeals Court, 1990)
Sound Techniques, Inc. v. Hoffman
737 N.E.2d 920 (Massachusetts Appeals Court, 2000)
Massachusetts Property Insurance Underwriting Ass'n v. Georgaklis
931 N.E.2d 995 (Massachusetts Appeals Court, 2010)
Von SCHönau-Riedweg v. Rothschild Bank AG
128 N.E.3d 96 (Massachusetts Appeals Court, 2019)

Cite This Page — Counsel Stack

Bluebook (online)
Centaur Diagnostics, Inc. v. Mittel, Counsel Stack Legal Research, https://law.counselstack.com/opinion/centaur-diagnostics-inc-v-mittel-mad-2019.